Use of Monoclonal Anti-EGFR Antibody in the Radioimmunotherapy of Malignant Gliomas in the Context of EGFR Expression in Grade III and IV Tumors-Reference-Cited by-同舟云学术

Use of Monoclonal Anti-EGFR Antibody in the Radioimmunotherapy of Malignant Gliomas in the Context of EGFR Expression in Grade III and IV Tumors

Published:2006-06 Issue:3 Volume:25 Page:125-132
ISSN:1554-0014
Container-title:Hybridoma
language:en
Short-container-title:Hybridoma

Author:

Wygoda Zbigniew¹,Kula Dorota¹,Bierzyńska-Macyszynz Grażyna²,Larysz Dawid³,Jarząb Michał⁴,Właszczųk Paweł²,Owski Piotr Baż³,Wojtacha Maciej³,Rudnik Adam³,Stępień Tomasz⁵,Kaspera Wojciech⁵,Etmańska Aleksandra¹,Składowski Krzysztof⁶,Tarnawski Rafał⁷,Kokocińska Danuta⁵,Jarząb Barbara¹

Affiliation:

1. Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie Memorial Institute and Center of Oncology, Gliwice, Poland.

2. Department of Pathology, Sosnowiec, Silesian University School of Medicine, Katowice, Poland.

3. Clinic of Neurosurgery, Katowice, Sosnowiec, Silesian University School of Medicine, Katowice, Poland.

4. Department of Tumor Biology, Maria Skłodowska-Curie Memorial Institute and Center of Oncology, Gliwice, Poland.

5. Clinic of Neurosurgery, Sosnowiec, Silesian University School of Medicine, Katowice, Poland.

6. 1st Clinic of Radiotherapy, Maria Skłodowska-Curie Memorial Institute and Center of Oncology, Gliwice, Poland.

7. Department of Radiotherapy, Maria Skłodowska-Curie Memorial Institute and Center of Oncology, Gliwice, Poland.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

http://www.liebertpub.com/doi/pdf/10.1089/hyb.2006.25.125

Reference38 articles.

1. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized radiation therapy for glioblastoma;Chinese Clinical Oncology;2024-02

2. Toxic warhead-armed antibody for targeted treatment of glioblastoma;Critical Reviews in Oncology/Hematology;2024-01

3. Nuclear medicine therapy of CNS tumors;Nuclear Medicine and Molecular Imaging;2022

4. Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects;Critical Reviews in Oncology/Hematology;2021-07

5. A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma;Theranostics;2021